All articles by Imogen Clegg

Pharma executives have faith in AI to solve the R&D optimization puzzle, says GlobalData

Digital transformation is the act of using new and emerging technologies to solve traditional problems. It is the idea that…
Multiple sclerosis market to reach $32.9bn in 2028 driven by launch of pipeline agents, says GlobalData

Multiple Sclerosis is an autoimmune disorder that involves recurring inflammatory attacks on the central nervous system. This is caused by…
Pharma industry is prioritizing big data, blockchain, cloud computing and cybersecurity for investments, according to survey by GlobalData

The healthcare industry is one of the biggest in the world and it is important for healthcare systems to communicate…
Reproductive Hormones and Protein Tests on the rise, says GlobalData

Reproductive hormones and protein tests are incredibly important for the pharmaceutical industry. They facilitate the control and regulations of many…
Huge unmet needs in glioblastoma multiforme market drives the future, says GlobalData

Glioblastoma multiforme (GBM), also known as Grade IV astrocytoma, is the most aggressive form of brain cancer and has one…

As prevalent cases of Multiple Sclerosis grow, new investment opportunities open up, says GlobalData

Multiple Sclerosis is an autoimmune disease affecting the central nervous system. The condition causes nerve sheath demyelination, followed by axon…
Global medical marijuana market set to reach US$3.2bn by 2025, says GlobalData

Marijuana, or cannabis, is a plant often associated with the use of recreational drugs. Although a frequent subject of taboo…
Biomarkers will play a key role in shaping the global CNS drug market, although cost remains a limiting factor, says GlobalData

A biomarker acts as an internal ‘fingerprint’, indicating the presence of biological conditions, pathogens, and processes. These small molecules have…
More and more people take seasonal influenza vaccinations, says GlobalData

The coming of ‘flu season’ every year causes patients of all backgrounds to visit their GP for vaccination. Seasonal influenza…
Global allergic rhinitis immunotherapy market set to reach $1.14bn by 2028, driven by growth in the US and Japan, says GlobalData

Allergic rhinitis (AR) is a common disease that causes sufferers to react adversely to otherwise innocuous inhaled substances. The most…